Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis
Friday, May 13, 2011 - 17:30
in Health & Medicine
The CAPACITY study, published Online First and in an upcoming Lancet, shows that pirfenidone reduces the rate of decline of lung function in patients with idiopathic pulmonary fibrosisa condition of unknown cause affecting hundreds of thousands of patients worldwide that leads to progressive lung decline and kills four in five patients within five years. The Article is by Professor Paul W Noble, Duke University Medical Center, Durham, NC, USA, and colleagues.